<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-153078</identifier>
<setSpec>0034-9356</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Changes in haemostasis and thrombosis associated with thyroid disease: Presentation of 2 cases</dc:title>
<dc:description xml:lang="en">There is a relationship between thyroid diseases and primary and secondary changes in haemostasis. The most frequent association between them are hypocoagulability states with clinical hypothyroidism and vascular thrombophilia (hypercoagulability and/or hypofibrinolysis) with hyperparathyroidism. However, there are recent studies that have detected changes in haemostasis &#150;primary and secondary&#150; associated with thyroid diseases with normal hormone levels, suggesting other pathogenic mechanisms not yet known. The cases are presented of 2 patients with thyroid disease that required surgery: one multinodular goitre and one papillary carcinoma of the thyroid, both with normal hormone levels. They were shown to have haemostasis disorders during the preoperative work up. These showed a Factor VII deficiency and a Factor XI deficiency along with a thrombotic disease of unknown origin, respectively (AU)</dc:description>
<dc:creator>Rodilla Fiz, AM</dc:creator>
<dc:creator>Gómez Garrido, M</dc:creator>
<dc:creator>Girón la Casa, M</dc:creator>
<dc:creator>Garví López, M</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Existe una relación entre las enfermedades tiroideas y las alteraciones de la hemostasia primaria y secundaria. La asociación más repetida en esta línea son los estados de hipocoagulabilidad con el hipotiroidismo clínico y la trombofilia vascular (hipercoagulabilidad y/o hipofibrinólisis) con el hipertiroidismo. Sin embargo, existen estudios recientes que han detectado alteraciones de la hemostasia &#150;primaria y secundaria&#150; relacionadas con enfermedades tiroideas con hormonas normales, evidenciando otros mecanismos patogénicos aún desconocidos. Presentamos el caso de 2 pacientes con enfermedades tiroideas que requerían cirugía: un bocio multinodular y un carcinoma papilar de tiroides, ambos con hormonas normales y que presentaron trastornos de la hemostasia descubiertos en el estudio preoperatorio, revelando un déficit de factor vii y un déficit de factor xi junto con una trombopatía no filiada, respectivamente (AU)</dc:description>
<dc:source>Rev Esp Anestesiol Reanim;63(6): 357-360, jun.-jul. 2016. tab</dc:source>
<dc:identifier>ibc-153078</dc:identifier>
<dc:title xml:lang="es">Alteraciones de la hemostasia y trombosis asociadas a enfermedad tiroidea, a propósito de 2 casos</dc:title>
<dc:subject>^d1805^s22012</dc:subject>
<dc:subject>^d1805^s22057</dc:subject>
<dc:subject>^d6191^s22012</dc:subject>
<dc:subject>^d5271^s22012</dc:subject>
<dc:subject>^d779^s22045</dc:subject>
<dc:subject>^d6191^s22057</dc:subject>
<dc:subject>^d14312^s22032</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d6191^s22009</dc:subject>
<dc:subject>^d14347^s22057</dc:subject>
<dc:subject>^d6641^s22021</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d14347^s22012</dc:subject>
<dc:subject>^d2334^s22009</dc:subject>
<dc:subject>^d14312^s22012</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d7160^s22012</dc:subject>
<dc:subject>^d2334^s22057</dc:subject>
<dc:subject>^d5271^s22036</dc:subject>
<dc:type>article</dc:type>
<dc:date>201607</dc:date>
</metadata>
</record>
</ibecs-document>
